In conclusion, ACTA2-AS1 inhibits GC cell viability, proliferation, migration, invasion, and EMT process and suppresses xenograft tumor growth by binding with miR-378a-3p to upregulate PLCXD2. Here, ACTA2 is linked to neoplasm.